Neurobiological Effects of Work-related Adjustment Disorder
NeuroWAD
1 other identifier
observational
82
1 country
1
Brief Summary
INTRODUCTION: Stress is one of the greatest burdens of our society and often imply impairments in cognitive and emotional functions. The investigators hypothesize that changes in the brain's dopamine(DA)-based mesocorticolimbic projections in patients with work-related stress (adjustment disorder) will manifest in altered glucose metabolism in relation to neural activity and altered DA radiotracer binding potential at neurotransmitter and receptor level. MATERIAL AND METHODS: Subjects and healthy controls undergo neuropsychiatric tests and PET/MR imaging with three tracers: \[18F\]FDG to measure glucose metabolism as a marker of neural activity, \[11C\]raclopride to investigate the DA binding potential in the striatum, and \[11C\]FLB 457 to study possible impaired mesocortical dopaminergic transmission. To demonstrate difference in glucose metabolism ≥2x41 patients/controls are needed. OUTCOME: The investigators expect to find that symptoms of cognitive and motivational/reward deficits could be attributable to changes in frontal lobe and striatal glucose metabolism in \>50% of patients and that changes in striatal D2 receptors and impaired mesocortical dopaminergic transmission in the prefrontal cortex are contributing factors. CONCLUSION: This project aims to generate entirely new and objective evidence of stress-induced cerebral illness and provide a basis for in depth research and more rational management of this strenuous disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2017
CompletedFirst Posted
Study publicly available on registry
November 7, 2017
CompletedStudy Start
First participant enrolled
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedSeptember 23, 2022
September 1, 2022
4.8 years
October 13, 2017
September 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose metabolism
PET/MR scan
3 year
Secondary Outcomes (1)
Dopamine binding potential
3-4 years
Study Arms (2)
Stress patients
Patients diagnosed with work-related Adjustment disorder
Controls
Healthy controls
Interventions
Observations of glucose metabolism and dopamine binding potential
Eligibility Criteria
The patients are recruited among women aged 18-64 years.
You may qualify if:
- Population and controls:
- Informed consent before study-related activity
- Aged 18 - 64
- Labour market suitability
- Study population:
- Patients: F43.2
You may not qualify if:
- Population, patients and controls:
- Comorbid diagnoses as for instance: cancer, cardiovascular disease, diabetes.
- Regular medication known to affect the central nervous system.
- Prior exposure to violence and other serious harassment in the workplace
- Psychosocial challenge in private life according to the screening criteria in the protocol.
- Other serious illness
- Metal in body
- Claustrophobia
- Pregnancy
- Confounding drug consumption
- Dependence e.g. alcohol, narcotics or other
- Persons within a period of 1 year have participated in scientific studies that use isotopes, or who have had greater diagnostic tests that utilize ionizing radiation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- University of Southern Denmarkcollaborator
- Rigshospitalet, Denmarkcollaborator
Study Sites (1)
Odense University Hospital
Odense, 5000, Denmark
Related Publications (1)
Madsen SS, Gjedde A, Brandt L, Pihl-Thingvad J, Videbech P, Gerke O, Hojlund-Carlsen PF. Neurobiological effects of work-related stress: protocol for a case-control neuroimaging study. Dan Med J. 2018 Nov;65(11):A5513.
PMID: 30382017DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saga Steinmann Madsen, Engineering
OUH
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Engineer
Study Record Dates
First Submitted
October 13, 2017
First Posted
November 7, 2017
Study Start
May 1, 2018
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
September 23, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share